Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

SHA:688016 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,086	2,171	2,967	976.89	1,243	1,051
Short-Term Investments	-	-	-	-	-	0.1
Cash & Short-Term Investments	2,146	2,171	2,967	976.89	1,243	1,051
Cash Growth	-32.49%	-26.84%	203.71%	-21.42%	18.26%	18.23%
Accounts Receivable	456.76	254.04	148.09	123.99	73.2	48.79
Other Receivables	2.59	0.84	1.03	0.86	0.71	-
Receivables	459.35	255.12	149.37	125.27	74.05	48.83
Inventory	234.21	266.4	210.89	155.97	106.92	82.06
Other Current Assets	41.86	48.04	38.06	36.2	34.42	14.53
Total Current Assets	2,881	2,740	3,365	1,294	1,459	1,197
Property, Plant & Equipment	418.24	411.76	335.32	225.84	117.12	53.56
Long-Term Investments	-	-	121.86	125.98	-	-
Goodwill	447.07	435.88	-	-	-	-
Other Intangible Assets	427.72	440.25	207.63	219.29	76.07	60.62
Long-Term Deferred Tax Assets	25.54	22.93	19.53	10.38	13.65	7.29
Long-Term Deferred Charges	195.22	185.98	173.99	97.42	78.7	50.31
Other Long-Term Assets	69.98	54.64	22.63	21.87	9.4	7.57
Total Assets	4,465	4,292	4,246	1,995	1,754	1,376
Accounts Payable	30.7	41.27	40.4	42.13	24.79	17.83
Accrued Expenses	49.42	154.27	137.32	78.07	95.14	80.34
Short-Term Debt	140	14	-	-	-	-
Current Portion of Leases	12.2	12.89	11.38	9.09	8.84	-
Current Income Taxes Payable	41.5	10.78	27.34	9.66	10.71	5.8
Current Unearned Revenue	17.54	4.57	1.86	2.53	2.16	2.72
Other Current Liabilities	167.17	101.26	94.47	45.36	20.4	7.97
Total Current Liabilities	458.52	339.04	312.76	186.83	162.05	114.66
Long-Term Leases	8.45	13.97	24.37	32.09	36.97	-
Long-Term Unearned Revenue	57.9	59.1	37.88	27.25	24.61	22.13
Long-Term Deferred Tax Liabilities	47.79	49.36	-	-	-	-
Other Long-Term Liabilities	7.66	7.65	7.62	6.32	7.84	5.3
Total Liabilities	580.32	469.13	382.63	252.49	231.47	142.09
Common Stock	123.26	123.26	82.73	71.98	71.98	71.98
Additional Paid-In Capital	2,655	2,656	2,623	834.99	818.33	809.09
Retained Earnings	1,276	1,147	1,137	809.71	603.98	352.91
Treasury Stock	-191.57	-120	-	-	-	-
Comprehensive Income & Other	-16.97	-13.71	1.59	1.99	-	-
Total Common Equity	3,846	3,792	3,844	1,719	1,494	1,234
Minority Interest	38.82	30.63	19.76	23.96	27.81	-
Shareholders' Equity	3,885	3,822	3,864	1,743	1,522	1,234
Total Liabilities & Equity	4,465	4,292	4,246	1,995	1,754	1,376
Total Debt	160.65	40.86	35.75	41.18	45.81	-
Net Cash (Debt)	1,985	2,130	2,931	935.71	1,197	1,051
Net Cash Growth	-36.89%	-27.34%	213.26%	-21.86%	13.90%	18.23%
Net Cash Per Share	16.07	17.26	27.21	8.73	11.17	9.80
Filing Date Shares Outstanding	121.31	122.37	123.26	107.25	107.25	107.25
Total Common Shares Outstanding	121.31	122.37	123.26	107.25	107.25	107.25
Working Capital	2,423	2,401	3,052	1,108	1,297	1,082
Book Value Per Share	31.70	30.99	31.18	16.03	13.93	11.51
Tangible Book Value	2,971	2,916	3,636	1,499	1,418	1,173
Tangible Book Value Per Share	24.49	23.83	29.50	13.98	13.22	10.94
Buildings	-	49.79	50.05	48.34	45.97	43.14
Machinery	-	138.16	99.48	80.2	58.67	36.84
Construction In Progress	-	288.27	205.96	100.65	2.25	2.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.